BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32847738)

  • 1. Efficacy of chemiluminescence in the diagnosis and screening of oral cancer and precancer: a systematic review and meta-analysis.
    Kim DH; Lee J; Lee MH; Kim SW; Hwang SH
    Braz J Otorhinolaryngol; 2022; 88(3):358-364. PubMed ID: 32847738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of toluidine blue in the diagnosis and screening of oral cancer and pre-cancer: A systematic review and meta-analysis.
    Kim DH; Song EA; Kim SW; Hwang SH
    Clin Otolaryngol; 2021 Jan; 46(1):23-30. PubMed ID: 32741142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autofluorescence imaging to identify oral malignant or premalignant lesions: Systematic review and meta-analysis.
    Kim DH; Kim SW; Hwang SH
    Head Neck; 2020 Dec; 42(12):3735-3743. PubMed ID: 32866310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of non-invasive diagnostic methods in the diagnosis and screening of oral cancer and precancer.
    Kim DH; Kim SW; Hwang SH
    Braz J Otorhinolaryngol; 2022; 88(6):937-947. PubMed ID: 33642212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficacy of chemiluminescence with lugol's iodine versus toluidine blue in the diagnosis of dysplasia in tobacco associated oral lesions - A diagnostic study.
    Swathi KV; Maragathavalli G; Uma Maheswari TN
    Indian J Dent Res; 2021; 32(4):459-466. PubMed ID: 35645072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effective is toluidine blue for screening and diagnosis of oral cancer and premalignant lesions?
    Mills S
    Evid Based Dent; 2022 Mar; 23(1):34-35. PubMed ID: 35338328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
    Awan KH; Morgan PR; Warnakulasuriya S
    Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene Blue as a Diagnosis and Screening Tool for Oral Cancer and Precancer.
    Hwang SH; Kim SW; Song EA; Lee J; Kim DH
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):271-276. PubMed ID: 32746769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
    Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
    J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
    Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
    Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review.
    Rashid A; Warnakulasuriya S
    J Oral Pathol Med; 2015 May; 44(5):307-28. PubMed ID: 25183259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The light at the end of the tunnel? Can light-based tests increase the accuracy of our diagnoses of pre-cancerous/cancerous lesions?
    Coll Y; Geddes A; Thomson E
    Evid Based Dent; 2022 Mar; 23(1):16-17. PubMed ID: 35338319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
    Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
    J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.
    Ram S; Siar CH
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):521-7. PubMed ID: 16053872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: Systematic review with meta-analysis.
    Fuller C; Camilon R; Nguyen S; Jennings J; Day T; Gillespie MB
    Head Neck; 2015 May; 37(5):755-62. PubMed ID: 24596227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of autofluorescence and chemiluminescence in the diagnosis of oral Dysplasia and Carcinoma: A systematic review and Meta-analysis.
    Moffa A; Giorgi L; Costantino A; De Benedetto L; Cassano M; Spriano G; Mercante G; De Virgilio A; Casale M
    Oral Oncol; 2021 Oct; 121():105482. PubMed ID: 34399191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive procedures for the recognition and diagnosis of oral precancer and cancer.
    Madhura MG; Rao RS; Patil S; Alhazmi YA; Jafer M; Habib SR; Awan KH
    Dis Mon; 2020 Dec; 66(12):101033. PubMed ID: 32620265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive visual tools for diagnosis of oral cancer and dysplasia: A systematic review.
    Giovannacci I; Vescovi P; Manfredi M; Meleti M
    Med Oral Patol Oral Cir Bucal; 2016 May; 21(3):e305-15. PubMed ID: 26946204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetic acid versus toluidine blue as screening tools for oral potentially malignant disorders.
    Winton Kalluvelil SR; Narayanan VS
    Indian J Cancer; 2023; 60(3):427-431. PubMed ID: 36861696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
    Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
    Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.